Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...

We need a reliable pipeline with new antibacterial agents that are innovative, affordable, accessible to all those who need ...

Crestone, Inc. ("Crestone") today announced recent publication in the leading infectious disease journal, The Lancet Infectious Diseases, of positive results from a Phase 2 clinical trial evaluating ...

ANTIMICROBIAL resistance in children is an escalating global health threat, responsible for a substantial proportion of infection-related deaths, particularly in those under 5 years of age. In Oceania ...

Please provide your email address to receive an email when new articles are posted on . However, this finding did not reach statistical significance, the researchers noted. “This is the first ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

This study was conducted at St. Mary's Hospital, a small community-based institution with approximately 200 beds, serving an urban population in Waterbury, Connecticut. Our catchment area included a ...

New findings highlight the importance of the host microbiota composition in the success of a treatment based on beneficial bacteria Antibiotic resistance is a major concern, particularly for ...